Merck appoints new CSO

pharmafield logo - pharma news


Merck has appointed Cuong Viet Do as Chief Strategy Officer, responsible for enterprise strategy and building connections between the franchises of the company.

He will report to Merck’s President and CEO, Kenneth C. Frazier, who says: “As the health care environment continues to evolve, Cuong’s expertise in developing and implementing global business strategy will help position Merck to deliver long-term value.”

Mr Do has been serving as Senior Vice President of TE Connectivity, formerly Tyco Electronic, since 2009. He also currently sits on the Board of WuXi AppTec, a pharmaceutical company that outsources R&D.

The new CSO said he was looking forward to “working with the exceptional employees at Merck to further define and implement strategies that can deliver on the company’s commitment to become the world’s leading health care company”.

He succeeds Mervyn Turner, who retired from the company this summer.